AllonM.. Treatment and prevention of hyperkalemia in end-stage renal disease.Kidney Int1993; 43: 1197–209.
2.
AllonM.. Hyperkalemia in end-stage renal disease: mechanisms and management.J Am Soc Nephrol1995; 6: 1134–42.
3.
AllonM., CopkneyC.. Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients.Kidney Int1990; 38: 869–72.
4.
LensX.M., MontoliuJ., CasesA., CampistolJ.M., RevertL.. Treatment of hyperkalemia in renal failure: salbutamo v insulin.Nephrol Dial Transplant1989; 4: 228–32.
5.
AllonM., DunlayR., CopkneyC.. Nebulized albuterol for acute hyperkalemia in patients on hemodialysis.Ann Intern Med1989; 110: 426–9.
6.
MontoliuJ., LensX.M., RevertL.. Potassium-lowering effect of albuterol for hyperkalemia in renal failure.Arch Intern Med1987; 147: 713–17.
7.
LiouH.H., ChiangS.S., WuS.C.. Hypokalemic effects of intravenous infusion or nebulization of sulbutamol in patients with chronic renal failure: comparative study.Am J Kidney Dis1994; 23: 266–71.
8.
BlumbergA., WeidmannP., FerrariP.. Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure.Kidney Int1992; 41: 369–74.
9.
GuttierezR., SchlessingerF., OsterJ.R., RietbergB., PerezG.O.. Effect of hypertonic versus isotonic sodium bicarbonate on plasma potassium concentration in patients with end-stage renal disease.Miner Electrolyte Metab1991; 17: 297–302.
10.
AllonM., ShanklinN.. Effect of albuterol treatment on subsequent dialytic potassium removal.Am J Kidney Dis1995; 26: 607–13.
11.
WilliamsA.J., BamesJ.N., CunninghamJ., GoodwinF.J., MarshF.P.. Effect of dialysate buffer on potassium removal during hemodialysis.Proc EDTA1984; 21: 209–14.
12.
ShermanR.A., HwangE.R., BernholcA.S., EisingerR.P.. Variability in potassium removal by hemodialysis.Am J Nephrol1986; 6: 284–8.
13.
WardR.A., WathenR.L., WilliamsT.E., HardingG.B.. Hemodialysate composition and intradialytic metabolic, acid-base and potassium changes.Kidney Int1987; 32: 129–35.
14.
GiffordJ.D., RutskyE.A., KirkK.A., McDanielH.G.. Control of serum potassium during fasting in end-stage renal disease.Kidney Int1989; 35: 90–4.
15.
AllonM., TakeshianA., ShanklinN.. Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia.Kidney Int1993; 43: 212–7.
16.
ArrizabalagaP., MontoliuJ., Martinez VeaA., AndreuL., Lopez PedretJ., RevertL.. Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosterone.Proc EDTA1983; 20: 572–6.
17.
CastellinoP., BiaM., DeFronzoR.A.. Adrenergic modulation of potassium metabolism in uremia.Kidney Int1990; 37: 793–8.
